key: cord-0855257-6ui36o34
authors: Hoffmann, H.-Heinrich; Schneider, William M.; Sánchez-Rivera, Francisco J.; Luna, Joseph M.; Ashbrook, Alison W.; Soto-Feliciano, Yadira M.; Leal, Andrew A.; Le Pen, Jérémie; Ricardo-Lax, Inna; Michailidis, Eleftherios; Hao, Yuan; Stenzel, Ansgar F.; Peace, Avery; Allis, C. David; Lowe, Scott W.; MacDonald, Margaret R.; Poirier, John T.; Rice, Charles M.
title: Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors
date: 2020-09-11
journal: bioRxiv
DOI: 10.1101/2020.09.11.291716
sha: 4a68c1541bb19ec2f38f824cac0a040ffd9f1fbf
doc_id: 855257
cord_uid: 6ui36o34

The ongoing SARS-CoV-2 pandemic has devastated the global economy and claimed nearly one million lives, presenting an urgent global health crisis. To identify host factors required for infection by SARS-CoV-2 and seasonal coronaviruses, we designed a focused high-coverage CRISPR-Cas9 library targeting 332 members of a recently published SARS-CoV-2 protein interactome. We leveraged the compact nature of this library to systematically screen four related coronaviruses (HCoV-229E, HCoV-NL63, HCoV-OC43 and SARS-CoV-2) at two physiologically relevant temperatures (33 °C and 37 °C), allowing us to probe this interactome at a much higher resolution relative to genome scale studies. This approach yielded several new insights, including unexpected virus and temperature specific differences in Rab GTPase requirements and GPI anchor biosynthesis, as well as identification of multiple pan-coronavirus factors involved in cholesterol homeostasis. This coronavirus essentiality catalog could inform ongoing drug development efforts aimed at intercepting and treating COVID-19, and help prepare for future coronavirus outbreaks. HIGHLIGHTS Focused CRISPR screens targeting host factors in the SARS-CoV-2 interactome were performed for SARS-CoV-2, HCoV-229E, HCoV-NL63, and HCoV-OC43 coronaviruses. Focused interactome CRISPR screens achieve higher resolution compared to genome-wide screens, leading to the identification of critical factors missed by the latter. Parallel CRISPR screens against multiple coronaviruses uncover host factors and pathways with pan-coronavirus and virus-specific functional roles. The number of host proteins that interact with a viral bait protein is not proportional to the number of functional interactors. Novel SARS-CoV-2 host factors are expressed in relevant cell types in the human airway.

The urgency of the ongoing SARS-CoV-2 pandemic has advanced coronavirus research at unprecedented speed. Two groups performed genome-wide CRISPR-Cas9 screens to identify host factors required by SARS-CoV-2 (Heaton et al., 2020; Wei et al., 2020) with the hope that these screens would not only uncover the biology underlying this virus, but also identify druggable host factors that could be targeted to prevent virus spread or lessen disease. Other groups conducted drug repurposing screens using compound libraries enriched with FDA-approved or clinical phase drug candidates to identify off-theshelf interventions (Dittmar et al., 2020; Zhou et al., 2020) . A complementary strategy to these screens is to nominate candidate host factors that are predicted to interact with viral proteins through immunoprecipitation mass spectrometry (IP-MS) of affinity tagged viral proteins. Indeed, one of the earliest discovery-based SARS-CoV-2 reports to appear in press was a study that aimed to map the SARS-CoV-2 host protein interactome using this technique (Gordon et al., 2020) . This dataset highlighted potential targets to explore for drug repurposing based on the hypothesis that host proteins that directly or indirectly bind SARS-CoV-2 proteins are more likely to be required to support infection or spread relative to the rest of the proteome. Similar protein interactome studies in different contexts and with varying degrees of overlap between datasets soon followed (Stukalov et al., 2020) .

While there is a pressing need to better understand SARS-CoV-2 biology and identify potential therapeutic targets, it is also critical to obtain and interpret this knowledge in the broader context of coronavirus biology to prepare for potential future outbreaks. We therefore aimed to use CRISPR-Cas9 technology to interrogate SARS-CoV-2 host factor requirements in a broader context that included additional members of the coronavirus family.

CRISPR-Cas9 forward genetics and data from IP-MS studies can be combined in a highcoverage hypothesis-driven sgRNA screening campaign . Focused libraries offer several advantages: 1) increased coverage (smaller libraries allow interrogation of many sgRNAs per gene, thereby lowering the rate of false-negatives), 2) increased resolution (smaller libraries ensure higher screen representation at every point of the screen), and 3) a wider range of screening conditions (smaller libraries are more compatible with highly parallel testing of multiple technical and biological conditions) Doench, 2018; Parnas et al., 2015) .

In this study, we leveraged the power of high resolution pooled CRISPR-Cas9 screens by generating and screening a focused sgRNA library targeting 332 host proteins identified by Gordon et al. as high-confidence SARS-CoV-2 protein interactors (Gordon et al., 2020) . This focused approach allowed us to interrogate 10 sgRNAs per gene, thereby achieving near-saturating coverage of candidate targets. Furthermore, the reduced library complexity allowed us to systematically expand our screening efforts across a panel of four related human coronaviruses representing both alpha-(HCoV-229E and HCoV-NL63) and beta-coronaviruses (HCoV-OC43 and SARS-CoV-2). We conducted these screens at 33 ºC and 37 ºC, consistent with the native environment of the upper and lower airway, respectively. This systematic approach allowed us to uncover host proteins that are required for infection by all four tested human coronaviruses.

Several of these host factors may serve as suitable targets for developing pancoronavirus therapeutics. Furthermore, we uncovered previously unappreciated differences in host factor requirements among human coronaviruses, which could be leveraged for designing strain-specific therapeutic strategies. Overall, our study highlights the power of high-coverage CRISPR-Cas9 screens for systematic identification of host factors required for coronavirus infection and serves as a resource for efforts aimed at developing novel strategies to treat COVID-19, seasonal coronavirus infections, and perhaps future pandemic strains.

In a recent study, 26 of the 29 known SARS-CoV-2 proteins were individually expressed in HEK293T cells and immunoprecipitated to identify interacting host proteins (Gordon et al., 2020) . After stringent filtering, 332 high-confidence host protein interactors were nominated. Here, we designed a custom-made sgRNA library and performed a series of CRISPR-Cas9 forward genetic screens to determine which of these 332 host proteins may be required for SARS-CoV-2 infection and virus-induced cytopathogenicity.

We constructed a lentiviral transfer plasmid library encoding 3,944 sgRNAs designed to disrupt all 332 human genes identified in the abovementioned SARS-CoV-2 interactome ( Figure 1A) . The library includes 10 sgRNAs targeting each gene, 314 safe-targeting sgRNAs (which cut the genome at non-genic regions (Morgens et al., 2017) ), and 310 sgRNAs targeting genes essential for cell survival or proliferation (Hart et al., 2017; Michlits et al., 2020) . We used this library to perform a pooled CRISPR-Cas9 gene disruption screen in Huh-7.5 hepatoma cells stably expressing Cas9 (Huh-7.5-Cas9) ( Figure 1B) . Huh-7.5 cells were chosen because they express the SARS-CoV-2 cellular receptor, angiotensin-converting enzyme 2 (ACE2), as well as transmembrane serine protease 2 (TMPRSS2), which is involved in SARS-CoV-2 entry ( Figure S1A ) (Hoffmann et al., 2020) . Furthermore, these cells express 329/332 (99%) of the host proteins in the SARS-CoV-2 interactome at levels similar to highly susceptible Calu-3 cells ( Figure S1A ) (Wyler et al., 2020) . Importantly, we confirmed that Huh-7.5 cells were readily infected and displayed virus-induced cytopathic effect (CPE) by multiple coronaviruses, including SARS-CoV-2, thereby validating these cells as a robust system for studying members of the Coronaviridae family ( Figure S1B ).

Next, we performed a series of genetic screens by transducing Huh-7.5-Cas9 cells with the SARS-CoV-2 interactome sgRNA library followed by puromycin selection and expansion for one week prior to SARS-CoV-2 challenge. To identify potential temperature-dependent differences in host factor requirements, SARS-CoV-2 selection screens were performed at two temperatures, 33 ºC and 37 ºC, to mimic the temperatures of the upper and lower airway, respectively (V'kovski et al., 2020) . Library-transduced cells that survived SARS-CoV-2 infection were harvested after seven (33 ºC) and eleven (37 ºC) days followed by genomic DNA isolation and screen deconvolution via next generation sequencing (Methods The overall technical performance of these genetic screens was excellent (Figure S1C-F). We confirmed that 3,921/3,944 (99.4%) of sgRNAs were recovered from the plasmid library and that all screen libraries were sequenced to saturation ( Figure S1C ).

Correlation analyses demonstrated that biological replicates for each condition clustered together and shared a high correlation coefficient (≥ .97), as expected ( Figure S1D ).

Receiver operating characteristic (ROC) curves, which measure the technical performance of genetic screens based on the degree to which the screen can distinguish between negative control (safe-targeting) and positive control (essential gene-targeting) sgRNAs, were excellent (Figure S1E-F). Of note, incorporating safe-targeting and essential gene-targeting sgRNAs allows for better internal calibration and effect size estimation of CRISPR-based genetic screens (Methods). Specifically, we used these built-in controls to establish a gene essentiality (beta) score (Li et al., 2015) , which allowed us to first stratify interactome targets based on their effects on cellular fitness under "mock" (uninfected) conditions followed by identifying high-confidence gene "hits" in infected cells (Methods). Genes with beta scores similar to essential genes (which influence cell survival with or without infection) may be confounded by effects on cellular fitness whereas genes with beta scores similar to safe-targeting sgRNAs (which only influence survival during viral infection) are more likely to be true positives. Using these parameters, we identified 36 and 43 genes that significantly influenced SARS-CoV-2induced cell death at 33 ºC and 37 ºC, respectively ( Figure 1C -D and Table S1C, E). Of these, 21 (33 ºC) and 23 (37 ºC) genes scored as potential host factors that promote SARS-CoV-2-induced cell death (purple dots in Figure 1C -D), while 21 (33 ºC) and 20

(37 ºC) genes scored as putative antagonists of the virus life cycle (orange dots in Figure   1C -D). In contrast, safe-targeting and essential gene-targeting sgRNAs behaved similarly across mock and SARS-CoV-2 conditions (blue and red dots in Figure 1C -D, respectively). These results suggest that the SARS-CoV-2 host protein interactome is composed of functionally relevant factors that play critical roles during the life cycle of this virus.

As shown in Figures 1C and 1D , we noted significant enrichment in sgRNAs targeting sterol regulatory element-binding protein (SREBP) cleavage-activating protein (SCAP), heparan sulfate 2-O-sulfotransferase 1 (HS2ST1), eukaryotic translation initiation factor 4E type 2 (EIF4E2), the Rab family of small GTPases (e.g., RAB2A, RAB10, and RAB14), members of the homotypic fusion and vacuole protein sorting (HOPS) tethering complex (e.g., VPS39 and VPS11), and ER Membrane Protein Complex Subunit 1 (EMC1).

Additional significantly enriched genes are highlighted in purple in Figures 1C and 1D .

These results indicate that these SARS-CoV-2 protein interactors are essential for virus infection or virus-induced cell death. In contrast, we observed negative enrichment in mammalian mitochondrial ribosomal small subunit (MRPS) genes (e.g., MRPS2, MRPS5, MRPS25, and MRPS27), suggesting that loss of these genes sensitize cells to direct or indirect virus-induced cell death. Additional significantly depleted genes are highlighted in orange in Figures 1C and 1D .

We also observed hits that were common to screens performed at either 33 ºC or 37 ºC ( Figure 1E ), as well as hits that were specific to one of the two temperatures. An intriguing outcome is the apparent differential requirement for two Rab GTPases, RAB2A and RAB14, which appear to be essential for SARS-CoV-2 infection and virus-induced CPE at 37 ºC but not at 33 ºC. In contrast, members of the HOPS complex (VPS11 and VPS39) and proteins involved in glycosylphosphatidylinositol (GPI) anchor biosynthesis (PIGO and GPAA1) appear to be required at 33 ºC but not at 37 ºC ( Figure 1E ). These findings may reflect differences in the SARS-CoV-2 entry pathway at 33 ºC and 37 ºC.

Lastly, we found that positively selected hits were typically enriched in the region of safetargeting sgRNAs, while negatively selected hits tended to be enriched in the region of control genes with deleterious effects ( Figure 1E ).

In conclusion, our SARS-CoV-2 interactome screen identified a compendium of host genes that can be disrupted without affecting cell viability in the absence of infection, yet seem to play essential roles during SARS-CoV-2 induced CPE ( Figure 1C -E). Such genes could represent excellent candidates for the development of anti-SARS-CoV-2 therapeutics.

Viruses within the same family can have both shared and specific host factor requirements. Functionally distinguishing these requirements is critical to gain a complete understanding of virus-host biology and, on a practical level, can help identify targets for pan-viral therapies. Towards these goals, we expanded our SARS-CoV-2 interactome CRISPR-Cas9 screening campaign by performing complementary screens using three additional human coronaviruses: HCoV-229E, HCoV-NL63, and HCoV-OC43. To visualize the degree of enrichment in genes that scored in the SARS-CoV-2 screens described above, we plotted the cumulative distribution of absolute z-scores for all five screens (Figure 2A) . Each of these screens were significantly enriched in the subset of genes that scored in the initial SARS-CoV-2 screens as compared to the complete library.

HCoV-OC43

HCoV-NL63 These screens also identified Rab GTPases, components of the HOPS complex, and EMC1 as host factors required for coronavirus infection and virus-induced CPE ( Figure   2B -D). In addition to hits common among different coronaviruses, several strain-specific hits were also identified ( Figure 2E ). For example, HCoV-OC43, for which there is currently no protein receptor described and entry has been associated with binding to 9-O-acetylated sialic acids (Hulswit et al., 2019) , displayed a unique requirement for GPI anchor biosynthesis as evidenced by the fact that GPAA1, PIGO, and PIGS scored as significant hits in the screen ( Figure 2D and Figure S4A ).

In addition to sgRNAs that enrich in virus-infected cell populations (suggesting the genes targeted by these sgRNAs support virus infection), we also identified sgRNAs that were depleted in virus-infected cultures (suggesting the genes targeted by these sgRNAs could have an antiviral function). For example, Mindbomb 1 (MIB1), an E3 ubiquitin-protein ligase, was specifically depleted in the context of infection with all four viruses. Although

disruption was consistently more toxic in the context of virus infection. MIB1 is known to play a role in 'Lys-63'-linked polyubiquitination of TBK1 kinase, which is thought to mediate its activation (Li et al., 2011) . Consistent with a potential role in this pathway, sgRNAs targeting TBK1 were negatively enriched in HCoV-229E and HCoV-OC43 screens ( Figure 2C-D) . This might suggest a role for MIB1 and TBK1, a signal integrator of multiple RIG-like receptors (RLRs) and positive regulator of IRF3, in establishing an antiviral state that controls coronavirus infection. This could explain why, in the absence of MIB1 and TBK1, cells are more susceptible to virus-induced CPE.

We next asked how the functional hits we identified related to the viral bait proteins with which they interact. To visualize functional and network relationships, we overlaid our CRISPR screening results from all viral screens in this study onto a bait-centric interactome map ( Figure 3A) . The distribution of functional hits across different bait proteins was apparently non-random; instead, we observed that certain bait proteins appeared to be enriched in functional hits.

We subsequently explored whether the number of host protein interactions for a given bait protein was predictive of the percentage of functional interactors ( Figure 3B ). There was no evident correlation between the number of predicted host protein binding partners of a given viral protein and the number of functional interactors. We found that some viral baits that interact with many host proteins (e.g., Orf8 and Nsp13) have relatively few functional interactors, whereas others (e.g., Nsp7, Nsp8, and Orf9c) have many. Overall, most of the functional hits identified in our pan-coronavirus screens seem to be required for SARS-CoV-2 infection. This was expected given that our screens were based on a SARS-CoV-2 protein interactome. We were surprised, however, to find that there are SARS-CoV-2 protein interactors that are essential for one or more of the other coronaviruses but not essential for SARS-CoV-2 (e.g., DDX10, RPL36, GNG5, and CYB5B; Figure 2E , 3A). Altogether, these data suggest that the relationship between physical interactome screens and functional genetic screens is not strictly concordant.

Some viral proteins may interact with redundant factors whose depletion is compensated.

However, 27% of SARS-CoV-2 interacting proteins functionally influenced the outcome of infection, suggesting that this high-confidence interactome is substantially enriched in functional host factors. 

Host:pathogen protein:protein interaction (PPI) networks derived from immunoprecipitation mass spectrometry (IP-MS) data have proven valuable for illustrating the complex nexus between viral and cellular proteins (Gordon et al., 2020; Sadegh et al., 2020; Stukalov et al., 2020) . PPI networks can predict hundreds of potential interactions; however, secondary validation of each interaction is often a labor-intensive process. Moreover, it is not possible to assign functional significance to any particular bona fide interaction based on co-purification or co-immunoprecipitation alone in part due to possible artifacts caused by overexpression outside of the viral context. Functional experiments are therefore needed to assess the biological significance of each host protein node in the network.

We probed a SARS-CoV-2 PPI network consisting of 332 high-confidence host factors by systematically screening multiple coronaviruses using a novel, high-density, pooled sgRNA library. First, we interrogated the functional role of each predicted member of the network in the presence or absence of SARS-CoV-2 infection, which allowed us to identify host factors that appear to be dispensable for Huh-7.5 proliferation but play a functional role in SARS-CoV-2 infection. Of the predicted interactome, we were able to assign a functional role for 87/332 (26%) unique genes. This finding is in contrast to two recent preprint studies that performed genome-scale CRISPR-Cas9 screens in VeroE6 and ACE2-reconstituted A549 cells, which failed to identify significant enrichment of the same PPI network (Heaton et al., 2020; Wei et al., 2020) . We speculate that this difference may be due in part to well-established advantages of focused screens, including 1) improved signal-to-noise ratios in the absence of sgRNAs targeting genes that are likely to dominate the screen (e.g., the SARS-CoV-2 cellular receptor, ACE2), 2) increased coverage by including more sgRNAs per gene (ten vs. four), 3) feasibility of exploring multiple screening conditions (e.g., different viruses and temperatures), and 4) higher screen representation (i.e., > 1,500-fold vs. < 750-fold) Doench, 2018; Parnas et al., 2015) ). Thus, by deeply probing individual interactome proteins using a focused sgRNA library coupled with functional readouts across multiple conditions allowed us to identify many host factors required for SARS-CoV-2 infection that were missed in genome-scale CRISPR screens (Heaton et al., 2020; Wei et al., 2020) .

While host proteins associated with specific viral bait proteins (e.g., Nsp7, Nsp8, and

Orf9c) appear to be enriched in functionally required host factors, we note that the greatest degree of co-essentiality was predominantly observed between functionallyrelated host factors instead of between factors associated with the same viral bait protein (e.g., SCAP and NPC2, both of which are involved in cholesterol homeostasis but interact with Orf9c and Orf8, respectively). This emphasizes the complementary role played by IP-MS data and functional genomics in identifying viral proteins that serve as hubs for multiple host factors that may participate in diverse molecular processes.

In addition to the pandemic SARS-CoV-2 strain, we performed parallel screens for three seasonal human coronaviruses (HCoV-NL63, HCoV-229E and HCoV-OC43), which allowed us to compare and contrast virus-specific host factor requirements and identify potential pan-coronavirus host factors. Many genes from the SARS-CoV-2 PPI network

were essential across multiple coronaviruses tested (40/332; 12%), suggesting functional conservation across host:coronavirus PPIs. Surprisingly, though, we found that some predicted SARS-CoV-2 interactors appeared not to play a role in SARS-CoV-2 infection but were essential for other coronaviruses (Figure 4A ). This may be due to promiscuity in protein-protein interactions, evolutionary divergence in the functional requirement for a given host factor, redundant factors (e.g., SARS-CoV-2 might rely on redundant factors

for specific viral life cycle steps while other coronaviruses might rely on a single factor), or the strict threshold-the ability to survive infection-that must be crossed to score as a hit in these screens. For example, it is possible that inactivation of specific host factors impairs SARS-CoV-2 infection to some extent but the virus nevertheless kills the cell.

To illustrate the power and versatility of our screening approach, we discuss below a specific example of pan-coronavirus and strain-specific host factors uncovered in our studies. The rest of the screening data can be found in Table S1 .

A central goal of this study was to use a predicted SARS-CoV-2 interactome to identify HCoV-NL63 33ºC

HCoV-229E 37ºC were also enriched across multiple coronavirus screens (Figure 4A-C) . NPC2 normally plays a role in trafficking cholesterol out of lysosomes (Infante et al., 2008) , and disruption of NPC2 could decrease cholesterol availability, which would prevent sequestration of SREBPs by SCAP and thus, phenocopy SCAP loss of function. EMC1 has been implicated in the exit of simian virus 40 (SV40) from the ER (Bagchi et al., 2016) , in the infection of many flaviviruses (Marceau et al., 2016; Savidis et al., 2016; Zhang et al., 2016) , and as part of the EMC complex in cholesterol biosynthesis (Volkmar et al., 2019) . SCAP and NPC2 have not been previously identified in other host:pathogen forward genetic screens; however, an upstream cholesterol transporter, NPC1, was identified as an essential host factor for Ebola virus (Carette et al., 2011) . The SCAP:SREBP complex is further regulated by oxysterol sensors, including insulin induced gene 2 (INSIG2), which sequesters SCAP:SREBP in the presence of oxysterols like 25-hydroxycholesterol (25OHC) (Radhakrishnan et al., 2007) . It is intriguing to speculate that oxysterols or direct SCAP inhibitors, such as fatostatin (Kamisuki et al., 2009) or its derivatives, could have antiviral properties. Consistent with this possibility, one study showed that 27hydroxycholesterol (27OHC) exerted SARS-CoV-2 antiviral activity in VeroE6 cells at 10 µM, and that overall oxysterols were lower in patients with moderate and severe COVID-19 symptoms compared to controls (Marcello et al., 2020) . Another study showed that 25OHC had potent SARS-CoV-2 antiviral activity at similar concentrations (Zang et al., 2020) . These findings are in strong agreement with work from multiple groups that has demonstrated that 25OHC is a potent inhibitor of many enveloped viruses (Liu et al., 2013) . Importantly, these regulators of lipid and cholesterol homeostasis are all constitutively expressed in Huh-7.5 cells (Figure 4B) , as well as in cells and tissues known to be infected by SARS-CoV-2 ( Figure S2) . Collectively, these results nominate regulators of lipid and cholesterol homeostasis as potential critical regulators of coronavirus infection and further suggest that direct targeting of SCAP may be a potential pan-coronavirus therapeutic strategy.

Another central goal of this study was to probe the SARS-CoV-2 interactome across multiple coronaviruses to identify host factors required for virus infection or virus-induced CPE by specific strains (e.g., SARS-CoV-2-specific factors that are dispensable for HCoV-NL63, HCoV-229E, and/or HCoV-OC43 infection). By comparing two temperatures and four coronaviruses in parallel, we uncovered striking heterogeneity in the requirement for different Rab GTPases, which varied by coronavirus and temperature ( Figure 4A-B, D) . Specifically, we identified a Rab GTPase module consisting of RAB2A

and RAB7A that appears to be critical for infection and virus-induced CPE by HCoV-229E, HCoV-OC43, and HCoV-NL63, but that seems to be partially dispensable for SARS-CoV-2 infection, at least at lower temperatures ( Figure 4A ). In accordance with these results, we identified the RAB10 and RAB14 GTPases as critical SARS-CoV-2-specific host factors while RAB5C appears to be specific for HCoV-OC43 infection (Table S1). This differential requirement is not due to differences in basal expression levels of Rab GTPases, as mRNAs for all five Rab proteins are uniformly expressed in Huh-7.5 cells, as well as in cells and tissues known to be infected by SARS-CoV-2 ( Figure 4B, Figure   S2 ). These results suggest that different coronaviruses may hijack specific Rab GTPase modules in host cells to carry out their infectious cycle, raising the possibility that targeting these modules could have therapeutic benefits. Furthermore, given the central role that Rab GTPases play in orchestrating complex intracellular trafficking, the observation that SARS-CoV-2 and HCoV-NL63, which both utilize ACE2 for cellular entry (Hoffmann et al., 2020; Hofmann et al., 2005) , have different requirements for Rab GTPases suggests that even coronaviruses that engage the same cellular receptor may differ in their entry pathways in a context-dependent manner. Moreover, the temperature-specific differences we observed among the same virus (SARS-CoV-2) raises the intriguing hypothesis that there may be differences in the infection process across the temperature gradient spanning the upper and lower airway. Recent studies have nominated additional SARS-CoV-2 entry factors, including (Gu et al., 2020) . One potential explanation for the temperature-specific differences we observed in entry pathways could be differential use of entry factors at 33 ºC and 37 ºC. In addition to virus-and temperature-specific differences in the requirement of Rab GTPases, we found that disruption of GPI anchor biosynthesis uniquely affected HCoV-OC43 (Figure 4A-B, E) , raising the tantalizing possibility that HCoV-OC43 engages one or more GPI-anchored host factors, potential receptors, or co-receptors, that facilitate entry upon binding to 9-O-acetylated sialic acids (Hulswit et al., 2019) .

This study leverages the power of CRISPR-Cas9 forward genetic screens to functionally probe a high-confidence SARS-CoV-2 host protein interactome across multiple coronaviruses and temperatures. In doing so, our study delineates the complex functional interplay between the interacting viral and host factors defined by Gordon et al. (Gordon et al., 2020) and nominates a set of core biological programs that play critical roles during infection by SARS-CoV-2 and other coronaviruses.. We found that a significant fraction of putative interactors in the SARS-CoV-2 interactome are indeed required for viral infection and virus-induced CPE by the pandemic SARS-CoV-2 and other endemic coronaviruses (HCoV-NL63, HCoV-229E, and HCoV-OC43). Interestingly, we identified one class of host factors that appear to be critical for infection by all coronaviruses tested (e.g., regulators of cholesterol homeostasis) and other classes of factors that seem to be required only by specific coronaviruses (e.g., Rab GTPases and GPI-anchoring proteins).

These findings fill an important knowledge gap between predicted and functional virushost interactomes and may help to focus attention on the genes and pathways in the SARS-CoV-2 interactome that appear to have the greatest functional significance during early infection steps. More broadly, this study presents a generalizable approach to interrogate host:pathogen PPI networks with functional genomics. We predict that the compendium of host factors and pathways described in this work will provide novel insights into the infection mechanics of SARS-CoV-2 and seasonal coronaviruses, while simultaneously nominating candidate targets for antiviral strategies.

While our study sheds new light on how host proteins are co-opted during coronavirus infection, it is not without limitations. As with all pooled CRISPR gene disruption screens, we expect that functionally redundant genes may not score (Ewen-Campen et al., 2017) ).

Additionally, the results of these genetic screens should not be interpreted to validate specific physical associations, as it is a purely functional readout. Additional biochemical studies would be necessary to test each predicted interaction. Nevertheless, we identified robust pan-coronavirus and discrete strain-specific host factors that scored with up to 10 sgRNAs scoring per gene, validating the utility of this near-saturation CRISPR-based genetic screening approach. We acknowledge that Huh-7.5 cells, which were chosen based on their unique capacity to support infection by multiple coronaviruses and also because they constitutively express 324/332 of the SARS-CoV-2 interactome factors, are different than the HEK293T system used by Gordon et al. to generate the PPI network probed in this study and are not airway cells. However, this robust and experimentally tractable system offers a unique advantage to directly compare hard-wired host factor requirements across multiple viruses in a cell-type-and tissue-type-agnostic manner, which can then be validated using gold-standard primary cells or animal models. Future studies will be required to dissect the specific requirement for each member of the PPI network validated in this study using additional models of coronavirus infection. Another potential limitation of our study is that the screening strategy is not optimal for assessing the functionality of host factors beyond their role in modulating cell survival. In other words, our current experimental set up does not allow for probing the functionality of interacting proteins or otherwise critical host factors that act in late stages of the viral life cycle. Furthermore, our approach cannot identify genes that play important roles in immune modulation and pathogenesis. Lastly, our genetic screens were not genomewide and, consequently, should not be interpreted as a comprehensive catalog of potential coronavirus host factors. Future studies that employ focused CRISPR-Cas9 libraries targeting other pathways of interest and/or high coverage genome-wide libraries will undoubtedly extend this catalog of host factors hijacked by human coronaviruses.

of the authors here were sustained during the shutdown by generous funding intended for related and unrelated work. During this time we were fortunate to obtain funding from government and charitable agencies that allowed this COVID-19 work to continue. For funding directly related to these COVID-19 efforts, we thank the G. Harold and Leila Y.

Mathers Charitable Foundation and the Bawd Foundation for their generous awards. We Regulus Therapeutics and Pfizer. The remaining authors declare no competing interests. Table S1 . CRISPR screen results. Table S1A : Huh-7.5 33 ºC HCoV-NL63 meta-zscore. Table S1B : Huh-7.5 33 ºC HCoV-OC43 meta-zscore. Table S1C : Huh-7.5 33 ºC SARS-CoV-2 meta-zscore.

Table S1D: Huh-7.5 37 ºC HCoV-229E meta-zscore. Table S1E : Huh-7.5 37 ºC SARS-CoV-2 meta-zscore. 

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contacts, John T. Poirier (John.Poirier@nyulangone.org) and

Charles M. Rice (ricec@mail.rockefeller.edu).

Plasmids and sgRNA cloning

To generate stable Cas9-expressing cell lines, we used lentiCas9-Blast (Addgene, cat.

#52962). To express sgRNAs, we used lentiGuidePurov2, a variant of lentiGuide-Puro (Addgene, cat. #52963) that contains an improved sgRNA scaffold based on Chen et al.

2013 (Chen et al., 2013) . For sgRNA cloning, lentiGuidePurov2 was linearized with BsmBI (NEB) and ligated with BsmBI-compatible annealed and phosphorylated oligos encoding sgRNAs using high concentration T4 DNA ligase (NEB). All sgRNA sequences used are listed in Table S1 . HIV-1 Gag-Pol and VSV-G plasmid sequences are available upon request.

Cloning of the Gordon et al. SARS-CoV-2 Human Interactome CRISPR Library sgRNA sequences (10 per gene) targeting 332 host factor proteins recently shown to interact with SARS-CoV-2 proteins (Gordon et al., 2020) (Table S1A) were designed using a combination of the Vienna Bioactivity CRISPR score (Michlits et al., 2020) and

the Broad Institute sgRNA Designer tool (Doench et al., 2016) . In addition, a subset of sgRNAs were hand-picked from the Wang-Sabatini genome-wide libraries (Wang et al., 2015) . We also included 314 safe-targeting sgRNAs (Morgens et al., 2017) and 310 sgRNAs targeting essential genes (Hart et al., 2017; Michlits et al., 2020) (Doench et al., 2016) to ensure a library representation of > 10,000-fold. Briefly, the oligo pool was selectively amplified using barcoded forward and reverse primers that append cloning adapters at the 5' and 3' ends of the sgRNA insert (Table S1B) Supernatants were subsequently harvested, clarified by centrifugation (3,000 g × 10 min) at 4 dpi (HCoV-229E), 6 dpi (SARS-CoV-2, HCoV-OC43) and 10 dpi (HCoV-NL63), and aliquots stored at -80 °C.

Viral titers were measured on Huh-7.5 cells by standard plaque assay. Briefly, 500 µL of serial 10-fold virus dilutions in Opti-MEM were used to infect 4 x 10 5 cells seeded the day prior into wells of a 6-well plate. After 90 min adsorption, the virus inoculum was removed, and cells were overlaid with DMEM containing 10% FBS with 1.2% microcrystalline cellulose (Avicel). Cells were incubated for 4 days (HCoV-229E), 5 days (SARS-CoV-2, HCoV-OC43) and 6 days (HCoV-NL63) at 33 °C, followed by fixation with 7% formaldehyde and crystal violet staining for plaque enumeration. All SARS-CoV-2 experiments were performed in a biosafety level 3 laboratory.

To confirm the identity of the viruses, RNA from 200 µl of each viral stock was purified by adding 800 µl TRIzol™ Reagent (ThermoFisher Scientific, cat. #15596026) plus 200 µl chloroform then centrifuged at 12,000 g x 5 min. The upper aqueous phase was moved to a new tube and an equal volume of isopropanol was added. This was then added to an RNeasy mini kit column (Qiagen, cat. #74014) and further purified following the manufacturer's instructions. Viral stocks were confirmed via next generation sequencing at the NYU Genome Technology Center using an Illumina stranded TruSeq kit and omitting the polyA selection step. Libraries were then sequenced by MiSeq Micro (2 x 250 bp paired end reads).

Huh-7.5-Cas9 cells were generated by lentiviral transduction of lentiCas9-Blast followed by selection and expansion in the presence of 5 µg/ml blasticidin. To deliver the lentiGuidePurov2 sgRNA library, 3.6 x 10 7 Huh-7.5-Cas9 cells were transduced by spinoculation at 1,000 g x 1 h in media containing 4 µg/ml polybrene (Millipore, cat. #TR-1003-G) and 20 mM HEPES (Gibco, cat. #15630080) at a MOI = 0.14 to achieve ~1,500fold overrepresentation of each sgRNA. Cells were spinoculated at 3 x 10 6 cells/well in 12-well plates in 1.5 ml final volume. Six hours post transduction, cells were trypsinized and transferred to T175 flasks at 6 x 10 6 cells/flask. Two days later, media was replaced with fresh media containing 1.5 µg/ml puromycin and expanded for six days prior to seeding for coronavirus infection.

CRISPR-Cas9 genetic screen Huh-7.5-Cas9 cells transduced with the lentiGuidePurov2 sgRNA library were seeded in p150 plates at 4.5 x 10 6 cells/plate in triplicate for each condition (mock, HCoV-229E, HCoV-NL63, HCoV-OC43, and SARS-CoV-2). The following day, the media was removed and viruses diluted in 10 ml/plate OptiMEM were added to cells. The inocula of Analysis of CRISPR-Cas9 genetic screen data FASTQ files were processed and trimmed to retrieve sgRNA target sequences followed by enumeration of sgRNAs in the reference sgRNA library file using MAGeCK (Li et al., 2014) . MAGeCK was also used to determine gene essentiality (beta) using its maximum likelihood estimation (MLE) algorithm. Z-scores for visualization in the form of heatmaps were computed using the following approach: for each condition, the log2 fold change with respect to the initial condition was computed. A natural cubic spline with 4 degrees of freedom was fit to each pair of infected and control cells and residuals were extracted.

To obtain gene-wise data, the mean residuals for each group of sgRNAs was calculated, a z-score was computed, and a p-value was determined using a 2-sided normal distribution test. P-values were combined across screens using Fisher's sumlog approach and corrected for multiple testing using the method of Benjamini & Hochberg.

RNAseq data from Huh-7.5 cells was obtained from GSE64677 (Luna et al., 2015) and processed using kallisto (Bray et al., 2016) followed by a tximport (Soneson et al., 2015) transcript-to-gene level transformation and then a limma-Voom approach (Ritchie et al., 2015) for read normalization. Transcript indices for kallisto were created from FASTA files from Ensembl release 100 for hg38 for all annotated cDNA and ncRNA transcripts. For

Calu-3 cells, data was obtained from GSE148729 (Wyler et al., 2020) . Specifically, count tables for poly-A selected libraries from bulk RNA sequenced Calu-3 cells were used and processed with the same limma-Voom read normalization scheme above. (Chua et al., 2020) . Using Seurat (Stuart et al., 2019) , average expression of single cell data by cell type was calculated using the AverageExpression() function with default parameters. Row normalized z-scores of these average expression values were plotted per cell type for all high confidence CRISPR hits.

Statistical tests were used as indicated in the figure legends. Generation of plots and statistical analyses were performed using the R statistical computing environment. Error bars represent standard deviation, unless otherwise noted. We used Student's t-test (unpaired, two-tailed) to assess significance between treatment and control groups, and to calculate P values. P < 0.05 was considered statistically significant.

Data supporting the findings of this study are reported in Supplementary Figures S1-S2

and Tables S1-S2. All raw data corresponding to high-throughput approaches (CRISPR screens, RNA-Seq) will be available through NCBI GEO. All reagents and materials generated in this study will be available to the scientific community through Addgene and/or MTAs. BRD4  VPS39  MEPCE  SBNO1  RAE1  NOL10  GIGYF2   ACE2   HECTD1  ZYG11B  RAB2A  HS2ST1  INTS4  EMC1  DDX10  TUBGCP2   VPS11  SRP54  BCS1L  SEPSECS   SCAP  MOGS  PIGO  PIGS  AP2M1  CSNK2B  RAB14  DCAF7  GPAA1  COMT  CSDE1  FAM98A  ALG5  CYB5B  G3BP1  ALG8  CSNK2A2   PRIM1  NUTF2  RPL36  RHOA  RAB7A  GNG5  NPC2  COLGALT1   RTN4  ATP6AP1  RAB10  ATP6V1A  PABPC1  DDX21  EIF4E2  LARP7 

EMC1-dependent stabilization drives membrane penetration of a partially destabilized non-enveloped virus

Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication

Near-optimal probabilistic RNA-seq quantification

Ebola virus entry requires the cholesterol transporter Niemann-Pick C1

Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system

COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis

Genetic screens in isogenic mammalian cell lines without single cell cloning

Drug repurposing screens reveal FDA approved drugs active against SARS-Cov-2

Am I ready for CRISPR? A user's guide to genetic screens

Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9

Accessing the Phenotype Gap: Enabling Systematic Investigation of Paralog Functional Complexity with CRISPR

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

Interaction network of SARS-CoV-2 with host receptome through spike protein

Evaluation and Design of Genome-Wide CRISPR/SpCas9 Knockout Screens. G3 (Bethesda)

SRSF protein kinases 1 and 2 are essential host factors for human coronaviruses including SARS-CoV-2. bioRxiv

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry

Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A

NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomes

A small molecule that blocks fat synthesis by inhibiting the activation of SREBP

Combined Proteomic and Genetic Interaction Mapping Reveals New RAS Effector Pathways and Susceptibilities

Mapping a dynamic innate immunity protein interaction network regulating type I interferon production

Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR

MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens

Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol

Hepatitis C Virus RNA Functionally Sequesters miR-122

Mechanisms and regulation of cholesterol homeostasis

Synthesis, Genetics, and Congenital Diseases of GPI-Anchored Proteins

Genetic dissection of Flaviviridae host factors through genome-scale CRISPR screens

The cholesterol metabolite 27-hydroxycholesterol inhibits SARS-CoV-2 and is markedly decreased in COVID-19 patients

Multilayered VBC score predicts sgRNAs that efficiently generate loss-of-function alleles

Genome-scale measurement of offtarget activity using Cas9 toxicity in high-throughput screens

A Genome-wide CRISPR Screen in Primary Immune Cells to Dissect Regulatory Networks

Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig

limma powers differential expression analyses for RNA-sequencing and microarray studies

Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing

Identification of Zika Virus and Dengue Virus Dependency Factors using

SREBP-regulated lipid metabolism: convergent physiology -divergent pathophysiology

Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences

Rab GTPases as coordinators of vesicle traffic

Comprehensive Integration of Single-Cell Data

Multi-level proteomics reveals hostperturbation strategies of SARS-CoV-2 and SARS-CoV

The ER membrane protein complex promotes biogenesis of sterol-related enzymes maintaining cholesterol homeostasis

Disparate temperature-dependent virus -host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium

Identification and characterization of essential genes in the human genome

Genome-wide CRISPR screen reveals host genes that regulate SARS-CoV-2 infection

Bulk and single-cell gene expression profiling of SARS-CoV-2 infected human cell lines identifies molecular targets for therapeutic intervention

Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion

A CRISPR screen defines a signal peptide processing pathway required by flaviviruses

Networkbased drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

This work was initiated and conducted under unusual circumstances. As New York City and much of the world was sheltering in place to reduce the spread of SARS-CoV-2, all